Discovery of new white blood cell reveals target for better vaccine design

Researchers in Newcastle and Singapore have identified a new type of white blood cell which activates a killing immune response to an external source -- providing a new potential target for vaccines for conditions such as cancer or Hepatitis B.
Enhanced by Zemanta

No comments: